Evidence map›Paper›PMID 30223446›Full record

ArticleMedicines (Basel, Switzerland)2018

Oleic Acid Nanovesicles of Minoxidil for Enhanced Follicular Delivery.

Pawan Kumar, Shailendra Kumar Singh, Vandana Handa, Himanshu Kathuria

Open access · goldAbstract read
In one paragraph

Article in Medicines (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Effect of topical nanoemulsion of minoxidil on animal hair growth: an in vivo study.Journal of materials science. Materials in medicine · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Sequential gentle hydration increases encapsulation in model protocells.bioRxiv : the preprint server for biology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Lipid-Based Nanovesicular Drug Delivery Systems.Nanomaterials (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Pawan KumarDepartment of Pharmaceutical sciences, Guru Jambheshwar University of science & Technology, Hisar 125001, India. pawansoni528@gmail.com.ORCID 0000-0001-8016-693X
Shailendra Kumar SinghDepartment of Pharmaceutical sciences, Guru Jambheshwar University of science & Technology, Hisar 125001, India. sksingh_gju@rediffmail.com.
Vandana HandaSchool of Pharmacy, Krishna Institute of Engineering and Technology, Ghaziabad 201206, India. vandanahanda1979@gmail.com.
Himanshu KathuriaNational University of Singapore, Singapore 117543, Singapore. a0120707@u.nus.edu.ORCID 0000-0002-9502-2901
Guru Jambheshwar University of Science and Technology · INNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current topical minoxidil (MXD) formulations involve an unpleasant organic solvent which causes patient incompliance in addition to side effects in some cases. Therefore, the objective of this work was to develop an MXD formulation providing enhanced follicular delivery and reduced side effects. Oleic acid, being a safer material, was utilized to prepare the nanovesicles, which were characterized for size, entrapment efficiency, polydispersity index (PDI), zeta potential, and morphology. The nanovesicles were incorporated into the emugel Sepineo

Indexed as

hair follicle deliveryminoxidiloleic acid vesicleskin depositionufasomes

Identifiers

PMID30223446
PMCPMC6165169
OpenAlexW2891953877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.